The International Symposium on Usher Syndrome held in Mainz on July 19-21, 2018 was a great success. An unprecedented number attendees from all over the world were present. More than 250 people from around the world attended the multi-day gathering in-person, and more than 150 joined the Patient Symposium via livestream, making it the single largest event ever held for the Usher syndrome community.
Retina International congratulates our newest member Retina Bulgaria on the launch of their new website https://retinabulgaria.bg/bg . This website brings information about retinal conditions and treatments to Bulgarian patients in their own language. It also creates awareness of the educational tools provided by Retina International's Toolkits for patients worldwide, by linking patients with RI's sites.
The International Council of Ophthalmology (ICO) is conducting an international search to fill a vacancy for the position of Chief Executive Officer (CEO) and is now accepting applications.
RP Fighting Blindness, the leading UK charity dedicated solely to working for people affected by inherited retinal conditions, has today rebranded to Retina UK. As well as a new name and visual identity, it has developed a new website www.RetinaUK.org.uk
On October 11th 2018, we celebrate World Sight Day, an annual day of awareness held on the second Thursday of October to focus global attention on blindness and vision impairment. The theme of World Sight Day 2018 (WSD2018) is Universal Eye Health and this year's ‘Call to Action’ is EYE CARE EVERYWHERE.
In order to understand the current status of the genetic testing pathway for IRD patients, we asked our members what the experiences are in their countries. Nine respondents from both EU and non-EU countries revealed disparities in test type availability, access and payment options. (Italy, Austria, Poland, Germany (two replies), Ireland, Iceland, Brazil, South Africa).
Welcome to the Retina International Website.
Apellis Pharmaceuticals Announces First Patient Dosed in Its Phase 3 Clinical Program for APL-2 in Patients With Geographic Atrophy
September 12, 2018
Inherited retinal diseases are forms of blindness where vision problems appear in children or young adults and can progress to total loss of sight. They are a collection of diseases that can be caused by one of over 200 known genes. The mutations of the RPE65 gene, which encodes one of the enzymes involved in the biochemistry of light capture by the cells of the retina, hinder the patient’s ability to detect light. It is a severely debilitating disease, characterised by a progressive loss of vision. Most patients will be blind by the time they are young adults.